GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Pre-Tax Income

Rhythm Pharmaceuticals (FRA:1RV) Pre-Tax Income : €-251.93 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Rhythm Pharmaceuticals's pretax income for the three months ended in Mar. 2024 was €-129.79 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-251.93 Mil. Rhythm Pharmaceuticals's pretax margin was -543.26%.

During the past 9 years, Rhythm Pharmaceuticals's highest Pretax Margin was -237.79%. The lowest was -2207.10%. And the median was -766.22%.


Rhythm Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Rhythm Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Pre-Tax Income Chart

Rhythm Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -126.66 -110.15 -61.61 -170.98 -168.83

Rhythm Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.74 -43.11 -41.04 -38.00 -129.79

Competitive Comparison of Rhythm Pharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Rhythm Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rhythm Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Rhythm Pharmaceuticals's Pre-Tax Income falls into.



Rhythm Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Rhythm Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-169.055+0.174+-12.739+12.788+-0.0010000000000048
=-168.83

Rhythm Pharmaceuticals's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-128.696+0.482+-4.375+2.802+0.0010000000000048
=-129.79

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-251.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhythm Pharmaceuticals  (FRA:1RV) Pre-Tax Income Explanation

Rhythm Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-129.786/23.89
=-543.26%

During the past 9 years, Rhythm Pharmaceuticals's highest Pretax Margin was -237.79%. The lowest was -2207.10%. And the median was -766.22%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhythm Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Pharmaceuticals (FRA:1RV) Business Description

Traded in Other Exchanges
Address
222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (FRA:1RV) Headlines

No Headlines